Genomic Revolution Multi-Sector ETF | TalkMarkets

Latest Posts

When Small Cap Biotechs Lose Momentum: Are You An Investor Or A Trader?

Article By: Rod Raynovich

Sunday, February 5, 2023 8:10 PM EDT

A few small cap biotechs lost momentum last week so now might be the time to take profits. But many of these stocks are favored because of their core technology and favored by funds; time to buy?

In this article: NTLA, IBB, PACB, XBI, SUPN, CRSP, ARKG, VCYT Also: CYRX, GERN, QDEL, HOLX, VRTX, EXAS, EVH, NVTA, TDOC

Read

Getting Ready For The Coming Stock Market Elevator Drop

Video By: Kirk Spano

Sunday, December 4, 2022 4:46 AM EDT

In this video Kirk Spano updates trends in Global ETFs and discusses why he thinks stocks are headed down in a big way.

In this video: QQQ, SOXX, EMB, PBW, XLE, ARKG, DAPP, ARKF

Watch

Check Your Portfolio For Small Cap Weighting: Growth, Innovation Or Speculation?

Article By: Rod Raynovich

Monday, August 15, 2022 5:12 AM EDT

The SPDR S&P Biotech ETF remains our key indicator for small cap biotechs. It is up 14.55% over one month at $93.78 but is still down 16% YTD. The Russell 2000 is up 16.5% over one month mirroring biotech small cap performance.

In this article: CYRX, QDEL, IWM, XBI, CCXI, EVH, ARKG, MRTX

Read

Small Cap Biotech Stocks Are Trending Well

Article By: Rod Raynovich

Monday, July 18, 2022 4:14 AM EDT

Despite a little weakness last week, small cap biotechs are trending well for traders. For investors entering the trade on July 5 all of our. focus stocks are up except ChemoCentryx.

In this article: REGN, PACB, EXAS, XBI, MRNA, TDOC, CRSP, ARKG, VCYT

Read